InvestSMART

BLS Pharmaceuticals Limited (ASX: BLS) - Announcements

Current share price for BLS : $0.935 0.01 (1.08%)+

ASX company news and announcements for BLS Pharmaceuticals Limited (BLS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BLS Pharmaceuticals Limited (BLS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BLS Pharmaceuticals Limited (BLS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BLS Pharmaceuticals Limited (BLS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$216 Letter to Shareholders re Annual General Meeting 23 Oct 2026 5:01PM $0.935 $0.935 fallen by 0%
$216 Notice of Annual General Meeting/Proxy Form 23 Oct 2026 4:48PM $0.935 $0.935 fallen by 0%
$216 Q1 FY2027 Quarterly Activities Update 21 Oct 2026 8:56AM $1.000 $0.935 fallen by 6.50%
$216 BLS Quarterly Activities Report September 2026 Revised 15 Oct 2026 9:19AM $1.085 $0.935 fallen by 13.82%
$216 Quarterly Activities/Appendix 4C Cash Flow Report 15 Oct 2026 8:28AM $1.085 $0.935 fallen by 13.82%
$216 Ceasing to be a substantial holder 13 Oct 2026 8:59AM $1.015 $0.935 fallen by 7.88%
$216 Becoming a substantial holder 9 Oct 2026 2:39PM $0.995 $0.935 fallen by 6.03%
$216 AGM Date and Director Nominations 7 Oct 2026 9:54AM $0.975 $0.935 fallen by 4.10%
$216 Application for quotation of securities - BLS 5 Oct 2026 11:46AM $1.000 $0.935 fallen by 6.50%
$216 Application for quotation of securities - BLS 28 Sep 2026 2:49PM $0.985 $0.935 fallen by 5.08%
$216 Initial Director's Interest Notice 15 Sep 2026 8:20AM $1.165 $0.935 fallen by 19.74%
$216 Angus Walker Appointed Alternate Director to Edward Myer 14 Sep 2026 8:25AM $1.180 $0.935 fallen by 20.76%
$216 Application for quotation of securities - BLS 10 Sep 2026 4:36PM $1.180 $0.935 fallen by 20.76%
$216 S&P DJI Announces September 2026 Quarterly Rebalance 4 Sep 2026 5:10PM $1.140 $0.935 fallen by 17.98%
$216 Application for quotation of securities - BLS 4 Sep 2026 5:07PM $1.140 $0.935 fallen by 17.98%
$216 Appendix 4G Corporate Governance Statement 31 Aug 2026 3:03PM $1.045 $0.935 fallen by 10.53%
$216 BLS FY2027 Guidance 31 Aug 2026 12:51PM $0.935 $0.935 fallen by 0%
$216 BLS Investor Presentation 31 Aug 2026 12:44PM $0.935 $0.935 fallen by 0%
$216 BLS FY2026 Results Announcement 31 Aug 2026 12:37PM $0.935 $0.935 fallen by 0%
$216 Annual Report to shareholders 31 Aug 2026 12:36PM $0.935 $0.935 fallen by 0%
$216 BLS FY2026 Results Webinar 2 September 2026 8am AEST 27 Aug 2026 11:51AM $0.930 $0.935 risen by 0.54%
$216 Application for quotation of securities - BLS 13 Aug 2026 8:12AM $0.930 $0.935 risen by 0.54%
$216 BLS to Present at Coffee Microcaps 31/7/2026 at 11.30 am 30 Jul 2026 4:59PM $0.800 $0.935 risen by 16.88%
$216 BLS Pharmaceuticals Investor Webinar Presentation 30 Jul 2026 8:57AM $0.780 $0.935 risen by 19.87%
$216 BLS Q4 FY2026 Results Investor Webinar 29 Jul 2026 2:46PM $0.780 $0.935 risen by 19.87%

1 - 25 of 70 results

Page 1 of 3

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.